Recombinant toxic shock syndrome toxin-1 variant vaccine(Biomedizinische Forschungsgesellschaft)

N/A

Report date: 2026/01/02 20:01:19

Base Information

Drug NameRecombinant toxic shock syndrome toxin-1 variant vaccine(Biomedizinische Forschungsgesellschaft)

Drug Alias NameRecombinant toxic shock syndrome toxin-1 variant vaccine(Biomedizinische Forschungsgesellschaft)中毒性休克综合征毒素变异重组疫苗rTSST-1 variant vaccine(Biomedizinische Forschungsgesellschaft)中毒性休克综合征toxin-1变体重组疫苗BioMed rTSST-1 variant vaccine(Biomedizinische Forschungsgesellschaft)

ClassificationVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsShock, Septic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustria

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBiomedizinische Forschungsgesellschaft

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBiomedizinische Forschungs Gmbh

Active IndicationsN/A

Inactive IndicationsShock, Septic

Other Information

ATC CodeN/A